{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:15:19Z","timestamp":1790792119824,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.amjcard.2015.01.014","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:15:24Z","timestamp":1421280924000},"page":"895-900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012)"],"prefix":"10.1016","volume":"115","author":[{"given":"Jing","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary G.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee M.","family":"Gindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carma","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleetwood","family":"Loustalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.01.014_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomized trials of antiplatelet therapy\u2014I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2015.01.014_bib2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.01.014_bib3","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.01.014_bib4","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2015.01.014_bib5","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2015.01.014_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/0003-4819-124-3-199602010-00002","article-title":"Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes","volume":"124","author":"Krumholz","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2015.01.014_bib7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/archinte.168.16.1813","article-title":"An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With the Guidelines quality improvement program","volume":"168","author":"Lewis","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2015.01.014_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ahj.2009.11.002","article-title":"Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals","volume":"159","author":"Xian","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2015.01.014_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.amjcard.2009.10.014","article-title":"Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)","volume":"105","author":"Cannon","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.01.014_bib10","series-title":"Aspirin Use Among the Adult Noninstitutionalized Population, With and Without Indicators of Heart Disease, 2005","author":"Soni","year":"2005"},{"issue":"suppl","key":"10.1016\/j.amjcard.2015.01.014_bib11","first-page":"11","article-title":"Recommended use of aspirin and other antiplatelet medications among adults\u2014National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.amjcard.2015.01.014_bib12","series-title":"Age Adjustment Using the 2000 Projected U.S. Population. Healthy People Statistical Notes No. 20","author":"Klein","year":"2001"},{"key":"10.1016\/j.amjcard.2015.01.014_bib13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/aje\/kwp440","article-title":"Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data","volume":"171","author":"Bieler","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjcard.2015.01.014_bib14","first-page":"1","article-title":"Design and estimation for the National Health Interview Survey, 2006\u20132015","author":"Parsons","year":"2014","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.amjcard.2015.01.014_bib15","series-title":"SUDAAN: Professional Software for Survival Data Analysis","author":"Frane","year":"1989"},{"key":"10.1016\/j.amjcard.2015.01.014_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1755-5922.2011.00291.x","article-title":"Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australia Cohort","volume":"31","author":"Ademi","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2015.01.014_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.01.014_bib18","first-page":"462","article-title":"Million hearts: prevalence of leading cardiovascular disease risk factors\u2014United States, 2005\u20132012","volume":"63","year":"2014","journal-title":"MMWR"},{"key":"10.1016\/j.amjcard.2015.01.014_bib19","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.01.014_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","article-title":"Effect of ibuprofen on cardioprotective effect of aspirin","volume":"361","author":"MacDonald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.01.014_bib21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2003.08.064","article-title":"The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin","volume":"43","author":"Kimmel","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.01.014_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2015.01.014_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3949\/ccjm.80a.12146","article-title":"Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events","volume":"80","author":"Park","year":"2013","journal-title":"Cleve Clin J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T08:54:31Z","timestamp":1537952071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0002914915000491"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.01.014","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}